New York, NY, United States of America

Hongliang Zong

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Cornell University, Sloan-Kettering Institute for Cancer Research. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hongliang Zong. Retrieved from https://idiyas.com/inventor/hongliang-zong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Hongliang Zong - Pioneering Innovations in New York

Introduction: Hongliang Zong is a distinguished inventor based in New York, NY, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Hongliang Zong holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With a career spanning over two decades, Hongliang Zong has worked with leading research institutions and tech companies, consistently pushing the boundaries of what is possible in the world of inventions.

Collaborations: Throughout his career, Hongliang Zong has collaborated with top scientists, engineers, and researchers globally, fostering a culture of innovation and knowledge-sharing in his field.

Conclusion: Hongliang Zong's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…